Natera Inc NTRA:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/12/21 EDT
87.16quote price arrow down-3.09 (-3.42%)
Volume
806,765
52 week range
39.21 - 127.19

...

Loading . . .
  • Open87.01
  • Day High90.32
  • Day Low86.01
  • Prev Close87.16
  • 52 Week High127.19
  • 52 Week High Date01/20/21
  • 52 Week Low39.21
  • 52 Week Low Date06/09/20

Key Stats

  • Market Cap7.665B
  • Shares Out87.94M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-12.42

KEY STATS

  • Open87.01
  • Day High90.32
  • Day Low86.01
  • Prev Close87.16
  • 52 Week High127.19
  • 52 Week High Date01/20/21
  • 52 Week Low39.21
  • 52 Week Low Date06/09/20
  • Market Cap7.665B
  • Shares Out87.94M
  • 10 Day Average Volume0.98M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change-12.42

RATIOS/PROFITABILITY

  • EPS (TTM)-3.10
  • P/E (TTM)-28.09
  • Fwd P/E (NTM)-20.89
  • EBITDA (MRQ)-235.086M
  • ROE (MRQ)-81.80%
  • Revenue (MRQ)449.31M
  • Gross Margin (MRQ)49.82%
  • Net Margin (MRQ)-57.47%
  • Debt To Equity (MRQ)88.48%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and...
Matthew Rabinowitz Ph.D.
Chairman
Steven Chapman
President
Robert Schueren
Chief Operating Officer
Michael Brophy
Chief Financial Officer
Address
13011 MCCALLEN PASS
BUILDING A SUITE 100
Austin, TX
78753
United States

Top Peers

SYMBOLLASTCHG%CHG
RARE
Ultragenyx Pharmaceutical Inc
106.40-2.08-1.92%
HALO
Halozyme Therapeutics Inc
42.48-0.20-0.47%
DNLI
Denali Therapeutics Inc
51.17-3.32-6.09%
SRPT
Sarepta Therapeutics Inc
73.89+2.87+4.04%
CRSP
CRISPR Therapeutics AG
100.84-2.70-2.61%